Publications by authors named "Di Andy Ai"

Article Synopsis
  • The study aimed to assess how consistently breast pathologists can evaluate low HER2 expression in metastatic breast cancer using trastuzumab deruxtecan and to create a better assessment method.
  • Six pathologists reviewed 106 cancer slides, with their agreement measured before and after training using a modified Ki-67 algorithm.
  • Results showed improved agreement among pathologists, but considerable challenges remain, indicating a need for a more reliable evaluation method for HER2-low breast cancer.
View Article and Find Full Text PDF